Table 3.
EORTC QLQ‐C30 scores at 3, 6 and 12 months after rectal resection
| 3 months | 6 months | 12 months | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Median (i.q.r.) | H–L* | P † | Median (i.q.r.) | H–L* | P † | Median (i.q.r.) | H–L* | P † | |
| Global quality of life | |||||||||
| Early | 75 (50–83·3) | 0 (−8·3, 8·3) | 0·941 | 66·7 (50–83·3) | 0 (−8·3, 8·3) | 0·961 | 83·3 (50–91·7) | 0 (−16·7, 8·3) | 0·889 |
| Late | 66·7 (58·3–83·3) | 66·7 (66·7–83·3) | 83·3 (66·7–91·7) | ||||||
| Physical functioning | |||||||||
| Early | 93·3 (73·3–100) | 0 (0, 6·7) | 0·634 | 93·3 (80–100) | 0 (−6·7, 0) | 0·433 | 93·3 (73·3–100) | 0 (−13·3, 0) | 0·137 |
| Late | 93·3 (73·3–100) | 93·3 (80–100) | 100 (80–100) | ||||||
| Role functioning | |||||||||
| Early | 83·3 (66·7–100) | −16·7 (−16·7, 0) | 0·066 | 100 (66·7–100) | 0 (0, 0) | 0·503 | 100 (66·7–100) | 0 (0, 0) | 0·793 |
| Late | 66·7 (50–100) | 83·3 (66·7–100) | 100 (66·7–100) | ||||||
| Emotional functioning | |||||||||
| Early | 83·3 (66·7–100) | 8·3 (0, 16·7) | 0·023 | 83·3 (66·7–100) | −8·3 (−16·7, 0) | 0·031 | 91·7 (66·7–100) | 0 (−8·3, 0) | 0·409 |
| Late | 91·7 (83·3–100) | 91·7 (75–100) | 91·7 (83·3–100) | ||||||
| Cognitive functioning | |||||||||
| Early | 100 (83·3–100) | 0 (0, 0) | 0·447 | 83·3 (83·3–100) | 0 (−16·7, 0) | 0·131 | 100 (66·7–100) | 0 (0, 0) | 0·652 |
| Late | 100 (83·3–100) | 100 (83·3–100) | 100 (83·3–100) | ||||||
| Social functioning | |||||||||
| Early | 83·3 (66·7–100) | 0 (0, 0) | 0·583 | 83·3 (66·7–100) | 0 (0, 0) | 0·882 | 83·3 (66·7–100) | 0 (−16·7, 0) | 0·142 |
| Late | 83·3 (66·7–100) | 83·3 (66·7–100) | 100 (66·7–100) | ||||||
*
Two‐sample Hodges–Lehmann (H–L) estimator with 95 per cent asymptotic confidence limits in parentheses. EORTC, European Organisation for Research and Treatment of Cancer.
†
Wilcoxon rank sum test for difference between early and late.